The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.

Luis-Gerardo Rodríguez-LobatoAlexandra Martínez-RocaSandra Castaño-DíezAlicia Palomino-MosqueraGonzalo Gutiérrez-GarcíaAlexandra PedrazaMaría Suárez-LledóMontserrat RoviraCarmen MartínezCarlos Fernández de LarreaMaría-Teresa CibeiraLaura RosiñolEster LozanoPedro MarínJoan CidMiquel LozanoAna Belén Moreno-CastañoMarta PalomoMaribel Díaz-RicartCristina GallegoAdelina HernandoSusana SeguraEnric CarrerasÁlvaro Urbano-IspizuaJoan BladéFrancesc Fernández-Avilés

Published in: PloS one (2020)

G-CSF avoidance and corticosteroid prophylaxis post ASCT minimize the incidence of NF in MM patients undergoing at-home ASCT. This approach should be explored in a prospective randomized clinical trial.

Keyphrases

stem cell transplantation
patients undergoing
high dose
multiple myeloma
end stage renal disease
ejection fraction
newly diagnosed
signaling pathway
bone marrow
prognostic factors
stem cells
clinical trial
low dose
cerebrospinal fluid
patient reported
mesenchymal stem cells
patient reported outcomes
nuclear factor